BioLife Solutions Inc expected to post a loss of 17 cents a share - Earnings Preview

BioLife Solutions

03/03/2023 21:06

* BioLife Solutions Inc  BLFS.OQ   BLFS.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 8
(estimated). 
    * The Bothell Washington-based  company is expected to
report  a
16.4% increase in revenue to $43.408 million from $37.3 million
a year ago, according to the mean estimate from 9 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for BioLife Solutions
Inc is
for a loss of 17 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for BioLife
Solutions
Inc is $30.5​, above​ its last closing price of $23.29. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.18       -0.17      -0.23     Missed  -35.3
 Jun. 30 2022  -0.23       -0.21      -0.06     Beat    72
 Mar. 31 2022  -0.25       -0.25      -0.17     Beat    31.1​
 Dec. 31 2021  -0.16       -0.17      -0.37     Missed  -119.5
 ​​Sep.        -0.09       -0.09      0.00      Beat    100
 30 2021                                                
 Jun. 30 2021  -0.09       -0.07      -0.12     Missed  -80​
 Mar. 31 2021  -0.04       -0.04      -0.03     Beat    21.7
 Dec. 31 2020              -0.02      -0.06     Missed  -180
 This summary was machine generated March 3 at 21:06 GMT.  All
figures in US dollars  unless otherwise stated